Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZW) Non-Current Deffered Revenue (2021 - 2025)

Core Scientific (CORZW) has disclosed Non-Current Deffered Revenue for 2 consecutive years, with $428.3 million as the latest value for Q4 2025.

  • Quarterly Non-Current Deffered Revenue changed N/A to $428.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $428.3 million through Dec 2025, changed N/A year-over-year, with the annual reading at $428.3 million for FY2025, N/A changed from the prior year.
  • Non-Current Deffered Revenue hit $428.3 million in Q4 2025 for Core Scientific, up from $12.1 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $428.3 million in Q4 2025 to a low of $12.1 million in Q1 2021.